Stockreport

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Werewolf Therapeutics, Inc.  (HOWL) 
PDF WATERTOWN, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company [Read more]